You’re on the news side, go back to data on Abbvie.De

News on Abbvie.De

41 days ago

Share

There has been 14 news on Abbvie.De in the past from 5 different sources and amongst 2 sections:

business (50%)
health (36%)

Latest news

Financial Times

41 days ago

AbbVie shares tumble after schizophrenia drug disappoints

42 days ago

Stocks making the biggest moves midday: AbbVie, Tesla, Cigna, Morgan Stanley and more

53 days ago

Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round up

Financial Times

243 days ago

Copycats take bite out of AbbVie's best-selling Humira drug

The Wall Street Journal

382 days ago

$19 Billion in a Week: AbbVie Makes Two Big Bets

The Wall Street Journal

382 days ago

$19 Billion in a Week: AbbVie Makes Two Big Bets

383 days ago

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion

The Wall Street Journal

384 days ago

AbbVie to Buy Cerevel Therapeutics for $8.7 Billion

The Wall Street Journal

390 days ago

AbbVie has agreed to buy biotech ImmunoGen for $10.1 billion in a bet on a promising novel drug technology for attacking cancer.

390 days ago

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

Going further

Evolution through time

Sources

There has been 5 publishers reporting on this, including: The Wall Street Journal (36%), Quartz (21%), CNBC News (21%), Financial Times (14%), Chicago Tribune (7%).

Details

This content can be used under the CC BY 4.0 license